Simone Oldani

Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Surgical Approach to Liver Metastasis from Gastroenteropancreatic Neuroendocrine Tumors in the Era of Precision Oncology.

Surgical Approach to Liver Metastasis from Gastroenteropancreatic Neuroendocrine Tumors in the Era of Precision Oncology.

Journal: Cancers

Published: March 30, 2026

Case Report: Personalized therapy in gynecological neuroendocrine neoplasm: a case of BRCA2-mutated ovarian neuroendocrine carcinoma treated with PARP-inhibitor.

Case Report: Personalized therapy in gynecological neuroendocrine neoplasm: a case of BRCA2-mutated ovarian neuroendocrine carcinoma treated with PARP-inhibitor.

Journal: Frontiers in oncology

Published: December 24, 2025

Real-world presentation and outcomes of gastroenteropancreatic neuroendocrine neoplasms in Italy: findings from the nationwide Itanet prospective database.

Real-world presentation and outcomes of gastroenteropancreatic neuroendocrine neoplasms in Italy: findings from the nationwide Itanet prospective database.

Journal: The Lancet regional health. Europe

Published: November 16, 2025

Early resident perceptions of clinical readiness in Italy: associations with demographic and educational factors.

Early resident perceptions of clinical readiness in Italy: associations with demographic and educational factors.

Journal: BMC medical education

Published: October 23, 2025

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials.

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 04, 2025

ctDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial.

ctDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 25, 2025

Design and rationale of the phase II PANDORA trial: first line chemo-immunotherapy in advanced Merkel cell carcinoma.

Design and rationale of the phase II PANDORA trial: first line chemo-immunotherapy in advanced Merkel cell carcinoma.

Journal: Future oncology (London, England)

Published: June 12, 2025

Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoids.

Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoids.

Journal: Endocrine

Published: September 28, 2024

Enhancing compassion in medical education - a comparative study of the efficacy of clinical clerkships versus simulation-based training methodologies.

Enhancing compassion in medical education - a comparative study of the efficacy of clinical clerkships versus simulation-based training methodologies.

Journal: BMC medical education

Published: July 13, 2024

Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial.

Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 02, 2024

Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future Perspectives.

Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future Perspectives.

Journal: Cancers

Published: April 25, 2024

Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma.

Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 29, 2024

Showing 1-12 of 22

Last Updated: 09/26/2026